Kentucky Spinal Cord Injury Research Center, University of Louisville, KY 40292, USA.
Neuropharmacology. 2012 Dec;63(7):1238-47. doi: 10.1016/j.neuropharm.2012.07.047. Epub 2012 Aug 5.
Endogenous ciliary neurotrophic factor (CNTF)(1) regulates neurogenesis of the adult brain in the hippocampal subgranular zone (SGZ)(2) and the subventricular zone (SVZ)(3). We have previously shown that the cAMP-inhibiting D2 dopamine receptor increases neurogenesis by inducing astroglial CNTF expression. Here, we investigated the potential role of CNTF in the proliferative response to pharmacological stimulation of the serotonin 1A (5-HT1A)(4) receptor, which also inhibits cAMP, in adult mice and rats. Like others, we show that systemic treatment with the active R-enantiomer of the 5-HT1A agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)(5) induces proliferation in the SGZ in rats using unbiased stereology of 5-Bromo-2'-deoxyuridine (BrdU)(6) positive nuclei. However, despite the bioactivity of R-8-OH-DPAT, as also shown by a decrease in hippocampal nNOS(7) mRNA levels, it did not increase CNTF mRNA as shown by highly specific quantitative RT-PCR (qPCR)(8). Surprisingly, R-8-OH-DPAT did not cause an increase in SVZ proliferation in rats or in either the SVZ or SGZ of two different strains of mice, C57BL/6J, and 129SvEv, using acute or chronic treatments. There also were no changes in CNTF mRNA, and also not in mice treated with a widely used racemic mixture of 8-OH-DPAT, higher doses or after intracerebral injection, which reduced nNOS. In contrast to the others, we propose that the 5-HT1A receptor might be non-functional in mice with regards to regulating normal neurogenesis and has region-selective activities in rats. These species- and region-specific actions raise important questions about the role of the 5-HT1A receptor in human neurogenesis and its implications for the field of depression.
内源性睫状神经营养因子 (CNTF)(1) 调节海马颗粒下区 (SGZ)(2) 和侧脑室下区 (SVZ)(3) 中成年大脑的神经发生。我们之前已经表明,通过诱导星形胶质细胞 CNTF 表达,cAMP 抑制的 D2 多巴胺受体增加神经发生。在这里,我们研究了 CNTF 在成年小鼠和大鼠中对 5-羟色胺 1A(5-HT1A)(4) 受体药理学刺激的增殖反应中的潜在作用,该受体也抑制 cAMP。与其他人一样,我们表明,用 5-HT1A 激动剂 8-羟基-2-(二正丙基氨基)四氢萘 (8-OH-DPAT)(5) 的活性 R-对映体全身治疗会诱导大鼠 SGZ 中的增殖,使用 5-溴-2'-脱氧尿苷 (BrdU)(6) 阳性核的无偏立体学。然而,尽管 R-8-OH-DPAT 具有生物活性,如海马 nNOS(7) mRNA 水平降低所示,它并没有像高度特异性定量 RT-PCR (qPCR)(8) 所示的那样增加 CNTF mRNA。令人惊讶的是,R-8-OH-DPAT 不会导致大鼠 SVZ 增殖增加,也不会导致两种不同品系的小鼠(C57BL/6J 和 129SvEv)的 SVZ 或 SGZ 增殖增加,无论是急性还是慢性治疗。CNTF mRNA 也没有变化,用广泛使用的 8-OH-DPAT 外消旋混合物、更高剂量或在脑内注射后处理的小鼠也没有变化,这会降低 nNOS。与其他人不同,我们提出 5-HT1A 受体在调节正常神经发生方面在小鼠中可能不起作用,并且在大鼠中具有区域选择性活性。这些种属和区域特异性作用提出了关于 5-HT1A 受体在人类神经发生中的作用及其对抑郁症领域的影响的重要问题。